|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Product and service revenue | ||||
| License and other revenue | ||||
| Other income | ||||
| Cost of product and service revenue | ||||
| Research and development expenses | ||||
| General and administrative expenses | ||||
| Operating profit | ||||
| Share of net loss of joint venture | ||||
| Impairment loss on investment in joint venture | ||||
| Loss on sale of interest in joint venture | ||||
| Effects resulting from business combination | ||||
| Finance income | ||||
| Finance costs | ||||
| Exchange rate differences | ||||
| Net gain / (loss) on modification and extinguishment of financial liabilities | ||||
| Non-operating profit / (loss) | ||||
| Profit / (loss) before taxes | ||||
| Income tax (expense) benefit | ||||
| Profit / (loss) for the year | ||||
| Other comprehensive profit / (loss) | ||||
| Item that will be reclassified to profit or loss in subsequent periods: | ||||
| Exchange rate differences on translation of foreign operations | ||||
| Total comprehensive profit / (loss) | ||||
| Profit / (loss) per share | ||||
| Basic profit / (loss) for the period per share (in dollars per share) |
Loading...
